Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves KRESLADI, first CIRM‑backed gene‑editing therapy
The FDA cleared KRESLADI, a gene‑editing treatment from Rocket Pharmaceuticals for severe leukocyte adhesion deficiency‑I in children, eliminating the need for a bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine to receive approval.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
UCB’s Senior Vice President Dr. Kim Moran discusses the company’s rare disease pipeline, including therapies for mitochondrial TK2 deficiency, on Xtalks Life Science Podcast episode 246. Moran, who pioneered UCB’s Insights‑to‑Impact function, explains how patient‑derived data informs strategy, digital transformation, and lifecycle management across neurology and epilepsy products. Her extensive leadership experience, highlighted by multiple industry awards, underscores UCB’s commitment to delivering innovative treatments to underserved populations. The episode also highlights her roles on Women in Bio and Nile AI boards.
Maven Clinic, known for its B2B telehealth services covering 28 million lives, has opened a beta waitlist for a new direct‑to‑consumer platform that will be available to women across the United States. The DTC offering bundles virtual access to more...
They refurbished the hospital… equipped it… and staffed it… and opened its doors to Zimbabweans from ALL WALKS OF life… Many have a testimony of their experience at Dr Tagwirei’s Arundel Hospital…. NOTHING says “LOVE FOR HUMANITY” better than that…...
At the 2026 HIMSS Global Health Conference, leaders highlighted a growing tension in digital health: rapid innovation can add complexity for clinicians and patients. They showcased Mass General Brigham’s AI‑powered ambient documentation, which after a pilot with 800 clinicians showed...
Lonza has broadened its agreement with Genetix Biotherapeutics to increase manufacturing capacity for ZYNTEGLO, the sole FDA‑approved gene therapy for transfusion‑dependent beta‑thalassemia. Production will continue at Lonza’s Houston, Texas, dedicated cell‑and‑gene therapy site, with provisions to scale up for future...
The article surveys seven early‑stage programmes tackling KRAS, each proposing a distinct therapeutic angle. While many firms still chase the classic model of deeper, longer, or more selective pathway blockade, these initiatives span elegant biochemical tricks to counterintuitive concepts that...
UF Health appointed Janice Walker as its inaugural chief nursing officer and introduced a seven‑day recruitment cycle to prevent losing qualified nurses. Walker frames slow hiring as a "never event," shifting the process from employer‑centric to candidate‑centric. The model relies...
A new HIMSS‑Elisity survey reveals that 62% of health systems cannot secure unpatchable or agentless IoMT devices, while 56% struggle with basic inventory visibility. The same respondents cite microsegmentation as the preferred defense, yet 40% fear it will disrupt clinical...
The U.S. Food and Drug Administration approved leucovorin, a synthetic vitamin B9, solely for cerebral folate deficiency, a rare genetic disorder. Earlier this year, President Trump and HHS Secretary Robert Kennedy Jr. promoted the drug as an autism cure, prompting a surge in...
The NHS serves an increasingly multilingual patient base, creating communication challenges that can jeopardise safety and equity. Professional medical translation services, such as Protranslate, offer secure, online workflows that deliver accurate documents in over 100 languages. These platforms employ subject‑matter...
At HIMSS 2026, Medicomp Systems CEO David Lareau warned that health systems are rapidly embedding generative AI into clinical documentation, coding and decision‑support workflows. While large language models promise efficiency, their probabilistic nature can introduce inaccuracies into patient records, jeopardizing...
St. Joseph’s/Candler health system in Savannah will launch a new residency program offering 103 positions across internal medicine, family medicine, cardiovascular disease fellowship, and general surgery. The initiative is backed by nearly $17 million in state funding approved in the 2026...
Brainomix has rolled out its AI imaging platform, Brainomix 360 Stroke, to all 25 sites in the West Virginia University Health System. The tool provides real‑time, automated analysis of stroke scans, helping clinicians decide on treatment and transfer. The deployment aims to...
Providence CFO Greg Hoffman will retire in June after nearly a decade with the nonprofit Catholic health system. He joined Providence in 2016, became chief transformation officer in 2019, and was appointed executive vice president and CFO in 2021. His...
American hospitals' operating expenses surged 7.5% in 2025, more than double the growth rate of hospital prices. The AHA report highlights sharp increases in drug costs (13.6%), medical supplies (9.9%), and workforce compensation, which now accounts for roughly 60% of...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on granting indefinite recognition to CE‑marked medical devices in Great Britain. Around 90% of devices used in the UK already carry CE marks, and the proposals aim...
Eli Lilly’s chief executive David Ricks announced a strategic push to sustain the company’s recent $1 trillion revenue milestone by accelerating AI‑driven drug discovery and manufacturing. He highlighted a new partnership with Nvidia to embed generative‑AI models across the R&D pipeline, aiming...
At HIMSS 2026, Buzz Health president Joseph Kleiman highlighted a fundamental shift in the prescription journey, moving from a linear claim flow to a complex, real‑time routing model that incorporates multiple pricing checks and benefit options. Advances in API‑based integrations...
Medtronic has promoted Sean Haag from interim to permanent president of its ear, nose and throat (ENT) business. Haag, who joined Medtronic twenty years ago and most recently oversaw marketing and clinical for the AiBLE system, has been credited with...
MiniMed Group, Inc. received CE Mark approval for its MiniMed 780G automated insulin delivery system to be used with Abbott's Instinct continuous glucose monitor, adding a 15‑day wear sensor to the existing 7‑day options (Guardian 4 and Simplera Sync). The Instinct sensor is...
Microsoft reported that its consumer AI tools, including Bing and Copilot, now field more than 50 million health‑related questions each day. An analysis of over 500,000 anonymized health conversations in January 2026 showed health is the top topic on mobile devices,...
Patrick Avila has been named president of Ascension Via Christi Hospital in Manhattan, Kansas, effective April 20, succeeding interim leader Drew Talbott. Avila arrives with more than 25 years of healthcare leadership, most recently as CEO of Northeast Regional Medical...
Researchers have engineered an antibody‑drug conjugate that simultaneously triggers HIV’s entry‑facilitating conformational shift and binds the newly exposed epitopes. In vitro tests showed the dual‑action molecule achieved seven‑ to ten‑fold greater neutralization than the antibody alone and outperformed separate mixtures...
Mankind Pharma used World Kidney Day to spotlight the escalating burden of chronic kidney disease (CKD) in India, where an estimated 138 million people are affected—far above the global average of 10 percent. The campaign highlighted the disease’s silent progression, noting that...
A 25-page executive overview of how six major categories of digital health devices evolved, and what their trajectories tell us about the future. If you want to understand the past decade of wearable evolution and the next decade of healthcare innovation,...
The KRAS niche has been a deluge of new selective and pan/multi inhibitors. Now there are combos to watch out for – we may be making progress. Here are insights on 7 of them: https://t.co/F9HmM8A4ud https://t.co/IqWw6n2m3k
The FDA has granted approval for leucovorin, a folinic‑acid formulation, to treat a rare metabolic disorder despite the absence of new clinical trial data. The decision leans on decades of off‑label use and historical safety records rather than prospective studies....
Another potential GLP-1 drug benefit seen in people with diabetes and brain metastases for improved survival; a retrospective study that needs further assessment but intriguing https://t.co/nZm3xEYQMH https://t.co/V76S7o1MJb
One fun takeaway from my Lilly story: looking at $LLY from a market cap/employee ratio. Far more in line with tech giants like $META $GOOG $MSFT than pharma peers like $MRK $AZN $PFE: https://t.co/pVIADCH8AU https://t.co/FJE8JLIrmO
WVU Medicine announced expansion of Abridge’s ambient AI platform to over 2,800 clinicians across its 25‑hospital network. The rollout, driven by clinician advocacy, aims to alleviate physician burnout in rural West Virginia. Post‑implementation surveys of more than 200 providers reported...
The blood neuromarkers p-tau181 and p-tau217 that can predict and diagnose Alzheimer's disease are also abnormal in certain types of amyloidosis, indicating both some non-specificity and potential help in diagnosis of these conditions https://t.co/jodvMY6TNK
A causal link between severe Covid or flu and lung cancer risk by impairing immunity and promoting inflammation, as shown in multiple murine models https://t.co/NvE6uIYFZh
The NHS Confederation’s report highlights that fragmented dental referrals are a core barrier to sustainable NHS dentistry. Digital referral optimisation, as demonstrated by NEC Rego, standardises forms, embeds clinical guidance and delivers real‑time data to Integrated Care Systems. Early pilots in...
NEW: I took a step back in looking at Lilly's ascent to the trillion-dollar club, and CEO David Ricks' actions in attempting to find "exit velocity" in the pharma industry + stay there: https://t.co/pVIADCH8AU
The Supreme Court is set to decide Chiles v. Salazar, a case challenging Colorado's ban on conversion therapy for minors. The dispute centers on whether talk‑based treatments aimed at changing sexual orientation or gender identity constitute protected speech or regulated...
Life Biosciences has secured FDA IND approval for ER-100, the first partial epigenetic reprogramming therapy to enter human trials. The gene‑therapy delivers OCT‑4, SOX‑2 and KLF‑4 to retinal ganglion cells via a single intravitreal injection, aiming to reset age‑related epigenetic...
The National Council on Compensation Insurance reports that opioid costs in workers’ compensation fell an average 2.8% annually from 2012 to 2023, dropping median claim expenses from $188 to $105. Meanwhile, topical medication spend rose from $38 to $62 per...
A burr hole drill is a specialized neurosurgical instrument that creates a small, precise opening in the skull to grant controlled access for a range of procedures. Modern designs feature high torque and automatic disengagement once the bone is penetrated,...
Astellas Pharma leveraged the Trump administration’s push for lower U.S. drug prices to argue for higher reimbursement for its eye drug Izervay in Japan, winning a more generous price level. Meanwhile, a review of FDA adverse event reports found that...
DNA damage repair gene alterations influence the tumor immune microenvironment in advanced non-small cell lung cancer [Feb 14, 2025] @KamyaSankar et al. @ReckampK Lung Cancer https://t.co/mXZ80zYke3 #lcsm #ImmunoOnc #PrecisionMedicine @TempusAI https://t.co/UJwZnw4qnc
Coloplast announced that former Johnson & Johnson executive Gavin Wood will assume the role of chief executive officer on May 1, ending a ten‑month search for a permanent leader. Wood arrives after serving as J&J’s group chairman for MedTech across Europe,...
Equatorial Guinea has launched a $116 million Vision 2030 malaria elimination strategy, building on two decades of success on Bioko Island where prevalence fell to 7.2 % in 2025. The programme aims to eradicate malaria nationwide, improve public‑health outcomes and remove a key...
The FDA is rolling out the Adverse Event Monitoring System (AEMS), replacing the legacy FAERS platform and consolidating reporting across drugs, biologics, devices, cosmetics, food, tobacco, and veterinary products. AEMS introduces standardized electronic submissions, AI‑driven redaction and analytics, and a...
CharmHealth has introduced CharmCopilot, an embedded multi‑agent AI assistant built directly into its electronic health record platform. The company is offering the core AI capabilities to existing customers at no additional charge, positioning the tool as a cost‑disruptive solution. Its...
The FDA is launching the Adverse Event Monitoring System (AEMS) to replace the legacy FAERS platform and bring together reporting for drugs, vaccines, devices, food, cosmetics, tobacco, and veterinary products. AEMS introduces standardized reporting protocols, AI‑driven redaction and digitization, and...
Healthcare organizations must prioritize staff safety to achieve clinical excellence. Research shows physical and psychological safety are top predictors of patient safety grades, and a 10% rise in staff turnover intent correlates with a 14% increase in inpatient mortality. Burnout...
Real-world clinical genomic analysis of Pts w/ BRAF mutated cancers identifies BRAF class II & III as a population of unmet medical need [3/7/22] Severson et al #ESMO2240P @TempusLabs https://t.co/s5PEBEczlv @Annals_OncologyDOI: https://t.co/c3wxWyUuX0 #PrecisionMedicine #caxtx
Researchers at ETH Zurich have introduced a boron‑based ligation strategy that overcomes the concentration barrier in chemical protein synthesis. By masking potassium acyltrifluoroborates (KATs) with chiral zwitterionic complexes, the team achieved efficient peptide coupling at micromolar levels, far lower than...
With $100M, Vima pursues an oral drug for movement disorders https://t.co/gLrhlYDMSy by @gwendolynawu #biotech #startups
Stamford Health, a 305‑bed independent system in Connecticut, has chosen Ensemble Health Partners to run its end‑to‑end revenue cycle management. Ensemble will apply its integrated operating model, AI‑driven analytics, and existing EHR infrastructure to automate billing, coding and denial recovery....
